We are live on ! Find out more
HCM

Highbridge Capital Management Portfolio holdings

AUM $3.09B
1-Year Est. Return 31.19%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+31.19%
3 Year Est. Return
+54.53%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.39%
AUM
$2.45B
AUM Growth
+$45M
Cap. Flow
-$1.31B
Cap. Flow %
-53.22%
Top 10 Hldgs %
43.27%
Holding
417
New
29
Increased
24
Reduced
15
Closed
57

Sector Composition

Rank Sector Weight
1 Communication Services 5.01%
2 Healthcare 1.66%
3 Utilities 0.76%
4 Technology 0.39%
5 Real Estate 0.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WESTW
26
DELISTED
Westrock Coffee Company Warrants
WESTW
0
HES
27
DELISTED
Hess
HES
$4.32M 0.18%
+30,000
New +$4.4M
CLVT icon
28
CALL
Clarivate
CLVT
$1.24B
$3.29M 0.13%
355,000
PCT icon
29
PUT
PureCycle Technologies
PCT
$1.41B
$3.24M 0.13%
800,000
+100,000
+14% +$439K
CLBTW
30
DELISTED
Cellebrite DI Ltd. Warrants
CLBTW
0
GRND.WS
31
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
0
THRX
32
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$2.5M 0.1%
+616,860
New +$1.88M
MARA icon
33
PUT
Marathon Digital Holdings
MARA
$4.48B
$2.35M 0.1%
+100,000
New +$1.26M
WALDW icon
34
Waldencast PLC Warrant
WALDW
$4.68M
0
CCTS
35
DELISTED
Cactus Acquisition Corp. 1 Limited Class A Ordinary Share
CCTS
$2.18M 0.09%
199,900
-10,000
-5% -$110K
UHGWW
36
DELISTED
United Homes Group Warrant
UHGWW
0
TBPH icon
37
Theravance Biopharma
TBPH
$874M
$1.87M 0.08%
166,234
-61,066
-27% -$615K
OKUR
38
OnKure Therapeutics
OKUR
$162M
$1.79M 0.07%
+112,170
New +$6.99M
VLD
39
DELISTED
Velo3D, Inc.
VLD
$1.66M 0.07%
+119,356
New +$4.59M
LVWR.WS icon
40
LiveWire Group Warrants
LVWR.WS
$8.16M
0
AFJKU
41
Aimei Health Technology Co Unit
AFJKU
$72M
$1.53M 0.06%
+150,000
New +$1.53M
VFSWW
42
VinFast Auto Ltd Warrant
VFSWW
$585M
0
RNWWW
43
ReNew Energy Global PLC Warrant
RNWWW
$61.1K
0
CNSL
44
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$1.34M 0.05%
+308,785
New +$1.28M
EVEX.WS icon
45
Eve Holding Inc Warrants
EVEX.WS
0
ZYXI
46
PUT
DELISTED
Zynex
ZYXI
$1.28M 0.05%
+117,500
New +$1.05M
GOSS icon
47
Gossamer Bio
GOSS
$84.9M
$1.2M 0.05%
1,310,477
-1,720,829
-57% -$1.27M
BE icon
48
PUT
Bloom Energy
BE
$64.3B
$1.15M 0.05%
+78,000
New +$976K
EVEX icon
49
CALL
Eve Holding
EVEX
$836M
$1.07M 0.04%
145,700
-75,500
-34% -$559K
PSQH.WS icon
50
PSQ Holdings, Inc. Warrants, Each whole warrant exercisable for 1/15th of a share of Class A common stock at an exercise price of $172.50 per share
PSQH.WS
$1.73M
0

Similar funds

Highbridge Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Highbridge Capital Management held 417 positions worth $2.45B, up 1.9% from $2.41B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Highbridge Capital Management withdrew a net $1.31B in Q4 2023, closing 57 positions and reducing 15 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $19.3M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 5% of assets, up from 4.6% a quarter earlier, followed by Healthcare and Utilities.

Against the trend, Highbridge Capital Management opened a new position in Capri Holdings worth $8.29M.

  • Highbridge Capital Management's largest Q4 2023 buy was Capri Holdings: 165,000 shares worth $8.29M.
  • Highbridge Capital Management added most to Amedisys in Q4 2023, an estimated $14.5M increase.
  • Highbridge Capital Management's biggest Q4 2023 reduction was Brookdale Senior Living Inc. 7.00% Tangible Equity Units, cutting an estimated $14M.
  • Highbridge Capital Management fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $19.3M.
  • Highbridge Capital Management's ten largest holdings make up 43% of its $2.45B portfolio in Q4 2023.
  • Highbridge Capital Management opened 29 new positions and closed 57 in Q4 2023.
  • Highbridge Capital Management's portfolio value rose 1.9% quarter-over-quarter to $2.45B.

Based on Highbridge Capital Management's 13F filing for Q4 2023, filed 12 Feb 2024.